Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 610-992-2 | CAS number: 53378-52-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 06, 1998 - September 05, 1998
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Also according to GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- (1997)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- (1992)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: US EPA (1997) Toxic Substances Control Act Test Guidelines; Title 40 Code of Federal Regulations Part 799
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Sodium O,O-diisobutyl phosphorothioate
- EC Number:
- 610-992-2
- Cas Number:
- 53378-52-2
- Molecular formula:
- C8 H18 O3 P S . Na
- IUPAC Name:
- Sodium O,O-diisobutyl phosphorothioate
- Test material form:
- other: grease-like solid
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): AERO® 6697 Promoter
- Name: Sodium diisobutyl monothiophoshate
- CAS: 53378-52-2
- Molecular formula: C8H18O3PS.Na
- Molecular weight: 248.26
- Storage condition of test material: not indicated in the study report
- Batch no.: 294
Test animals
- Species:
- mouse
- Strain:
- Swiss
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Limited, Margate, Kent, UK
- Age at study initiation: no data
- Weight at study initiation: males: 28 -30 g; females: 22 - 24 g
- Assigned to test groups randomly: yes
- Fasting period before study: no data
- Housing: Group housed per sex in plastic disposable cages
- Diet: Free access to pelleted expanded rat and mouse No.1 maintenance diet (SQC grade obtained from Special Diets Services Ltd, Witham, Essex, UK)
- Water: Free access to tap water
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 23
- Humidity (%): 52 to 66
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: purified water was used for the dilutions.
- Lot/batch no.: Water for irrigation, obtained from Baxter, batch numbers 98E29B25 and 98F29B28 - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Solutions/suspensions of the test substance were freshly prepared on the morning of the test and were diluted to the concentrations in purified water.
Dosing volume administered: 20 mL/kg body weight. - Duration of treatment / exposure:
- Test substance and negative control: 24 and 48 hours.
Positive control: 24 hours. - Frequency of treatment:
- Single
Doses / concentrationsopen allclose all
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 2 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- Pre test: 2
Main study: vehicle and 2000 mg/kg bw: 10/sex; 500 and 1000 mg/kg bw: 5/sex - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Mitomycin C in purified water (0.6 mg/mL)
- Route of administration: Single by intragastric gavage.
- Doses / concentrations: 12 mg/kg body weight (20 mL/kg body weight)
Examinations
- Tissues and cell types examined:
- Measuring the increase in the incidence of micronucleated immature erythrocytes per 2000 polychromatic erythrocytes in mouse bone marrow.
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: Selection of an adequate dose for the Micronucleus test was based on a preliminary study.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
At the beginning of the treatment the animals were weighed and the individual volume to administered was adjusted to the animal's body weight. Sampling of the bone marrow was done 24 (5/sex/dose) and 48 (5/sex for control and 2000 mg/kg bw) hours after treatment.
DETAILS OF SLIDE PREPARATION:
The animals were killed by cervical dislocation and both femurs dissected out from each animal. The femurs were cleared of tissue and the proximal epiphysis removed from each bone. The bone marrow of both femurs from each animal was flushed out and pooled in a total volume of 2 mL of pre-filtered foetal calf serum. The cells were sedimented by centrifugation, the supernatant was discarded and the cells were resuspended in a small volume of fresh serum. A small drop of the cell suspension was transferred to a glass microscope slide and a smear was prepared in the conventional manner. The prepared smears were fixed in methanol. After air-drying the smears were stained for 10 minutes in 10% Giemsa. Following rinsing in distilled water and differentiation in buffered distilled water (pH 6.8), the smears were air-dried and mounted with coverslips using DPX.
METHOD OF ANALYSIS:
The stained smears were examined by light microscopy to determine the incidence of micronucleated cells per 2000 polychromatic erythrocytes per animal. The proportion of immature erythrocytes for each animal was assessed by examination of at least 1000 erythrocytes. - Evaluation criteria:
- A positive response is normally indicated by a statistically siginificant dose-related increase in the incidence of micronucleated immature erythrocytes for the treatment group compared with the concurrent control group (P<0.01); individual and or/group mean values should exceed the laboratory historical control range.
A negative result is indicated where individual and group mean incidences of micronucleated immature erythrocytes for the group treated with the test substance are not significantly greater than incidences for the concurrent control group (P>0.01) and where these values fall within the historical control range. An equivocal response is obtained when the results do not meet the criteria specified for a positive or negative response. - Statistics:
- For incidences of micronucleated immature erythrocytes , exact one-sided p-values are calculated by permutation (StatXact, CYTEL Software Corporation, Cambridge, Massachussetts.)
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 250, 500, 1000 and 2000 mg/kg
- Solubility: The test substance was diluted in purified water.
- Clinical signs of toxicity in test animals: No clinical signs were observed in the 200 and 500 mg/kg tretament groups. After dosing with 1000 mg/kg lethargy and piloerection was observed in animals but the animals recovered within 3.5 hours. In the dose group of 2000 mg/kg lethargy, piloerection and ptosis was observed in all animals but the animals recovered within 5.5 hours.
- Results showed that a dose of 2000 mg/kg, the limit dose for the micronucleus test, was expected to be tolerated; this level was therefore selected as an appropriate maximum for use in the micronucleus test.
RESULTS OF DEFINITIVE STUDY see "attached background material for details on results"
- Induction of micronuclei (for Micronucleus assay): The test substance did not cause any statistically significant increases in the number of micronucleated immature erythrocytes at either sampling time. The test substance did not cause any substantial increases in the incidence of micronucleated mature erythrocytes at either sampling time.
- Ratio of PCE/NCE (for Micronucleus assay): The test substance did not cause any significant decreases in the proportion of immature erythrocytes.
Any other information on results incl. tables
- Clinical signs and mortalities: In the dose groups of 500, 1000 and 2000 mg/kg lethargy and unsteady gait was observed in all animals but the animals recovered within 4.5 hours. One female animal died after treatment with the test substance at the 2000 mg/kg dose level. A post mortem examination showed that this animal probably died as result of internal bleeding very occasionally associated with administration of substances by the intraperitoneal injection.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
An in vivo micronucleus study with the test material in the mouse (24 hours (5/sex/dose) and 48 hours (5/sex for control and 2000 mg/kg bw) sampling, intraperitoneal injection) was conducted according to OECD 474 and GLP guidelines. Based on the absence of increased number of micronucleated immature erythrocytes, it is concluded that the test material is not clastogenic in the in vivo micronucleus test. - Executive summary:
An in vivo micronucleus study with Aero® 6697 Promoter, a 50% solution in water, in the mouse ((24 hours (5/sex/dose) and 48 hours (5/sex for control and 2000 mg/kg bw) sampling, intraperitoneal injection) was conducted according to OECD 474 and GLP guidelines.
In the dose groups of 500, 1000 and 2000 mg/kg lethargy and unsteady gait was observed in all animals but the animals recovered within 4.5 hours. One female animal died after treatment with the test substance at the 2000 mg/kg dose level, this animal probably died as result of internal bleeding very occasionally associated with intraperitoneal administration of substances. No adverse clinical signs were obtained for the vehicle or positive control treated animals.
The test substance did not cause any statistically significant increases in the number of micronucleated immature erythrocytes at either sampling time. The test substance did not cause any significant decreases in the proportion of immature erythrocytes. Based on the these results, it is concluded that Aero® 6697 Promoter, a 50% solution in water, is not clastogenic in the micronucleus test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.